Opportunities
Search

Buyer: Chemins de fer fédéraux suisses CFF, Infrastructure – Achats, Supply Chain et production, Achats projets de construction Région Centre | Notice type: cn-standard | Procedure: open | Contract: services | Deadline: 2026-09-14

Buyer: Eskilstuna kommun | Notice type: cn-standard | Procedure: open | Contract: services | Deadline: 2026-09-14

Buyer: Region Stockholm - Förvaltning för utbyggd tunnelbana | Notice type: cn-standard | Procedure: neg-w-call | Contract: works | Deadline: 2026-09-14

Buyer: Metropole Toulon-Provence-Mediterranee | Notice type: cn-standard | Procedure: open | Contract: services | Deadline: 2026-09-14

Buyer: Gemeente Velsen | Notice type: pin-rtl | Procedure: open | Contract: services | Deadline: 2026-09-14

Summary: The fiscal year 2026 (FY26) Neurofibromatosis Research Program (NFRP) Neurofibromatosis Research Academy – Leadership Award (NFRALA) supports visionary, established neurofibromatosis (NF) investigators with documented history of neurofibromatosis funding, publications, strong mentorship and commitment to leadership to serve as Director and Deputy Director of the Neurofibromatosis Research Academy. The Academy Director and Deputy Director will execute a multi-institutional, interactive, virtual research academy that consists of scholars, who are early-career investigators, and their career guides, who serve as the scholars’ primary mentors.Distinctive Features:• Academy Director: Established NF investigators at or above the level of Associate Professor, or equivalent, at the full application submission deadline.• Academy Deputy Director: Investigators at or above the level of Associate Professor, or equivalent, at the full application deadline and affiliated with a different institution than the Academy Director.• Pilot Research Project: The Academy Director and Deputy Director will conduct one or more pilot research projects in collaboration with the academy scholars. Preliminary and/or published data relevant to NF and the proposed research project are encouraged but not required.

See the application guidelines and instructions at arts.gov for more information.

Expected Outcome:Activities under this topic respond directly to the goal of the Mission Soil to set up 100 living labs and lighthouses to lead the transition to healthy soils by 2030 and support the specific objectives of the Mission Soil.Activities should also contribute to the Common Agricultural Policy, and to meeting the European Green Deal ambitions and targets and more specifically those of the EU Biodiversity Strategy for 2030, the EU soil strategy for 2030 and the proposal for a Soil Monitoring and Resilience Directive, the Zero Pollution Action Plan, the EU Forest Strategy, as well as to the Sustainable Development Goals[1].Project results are expected to contribute to all the following expected outcomes:enhanced capacities for participatory, interdisciplinary and transdisciplinary R&I to co-create, and co-implement economically viable soil health solutions tailored to managed...

Expected Outcome:Project results are expected to contribute to all of the following expected outcomes:farmers, advisors, agri-food chain operators, policy-makers, public funders and citizens benefit from new knowledge and knowledge exchange, viable innovations, practices and tools that boost the competitiveness, sustainability (economic, environmental, social) and resilience of the organic farming sector;knowledge and innovations contribute to an improved sustainability of organic farming systems and an overall improved efficiency of the sector, leading to an increased attractiveness of organic farming in Europe and an improved understanding of its contribution to sustainability (economic, social, biodiversity, climate);the EU regulatory framework for organic farming, the Common Agricultural Policy, and the EU’s biodiversity, zero pollution and climate policies are supported by science-b...

Expected Outcome:Proposals under this topic should aim to deliver results that are directed and tailored towards and contribute to the following expected outcomes:Through the European Cancer Patient Digital Centre (ECPDC), adolescent and young cancer patients and survivors as well as their caregivers have access to innovative tools and approaches to strengthen their mental health;Healthcare professionals have access to innovative tools to monitor and support the mental health of cancer patients and survivors as well as their caregiversResearchers and healthcare professionals have access and use reliable patient reported data to better understand the mental health needs of cancer patients and survivors and provide effective care. Scope:As part of its citizens engagement activities, the EU Cancer Mission has launched a dialogue with young cancer survivors, to better understand the specific...

Expected Outcome:Proposals under this topic should aim to deliver results that are directed and tailored towards and contribute to all of the following expected outcomes:Patients with refractory cancers and their caregivers/families will have access to optimised, tailored and affordable immunotherapeutic interventions that increase their quality of life, across European regions, EU Member States and Associated Countries;Healthcare professionals and academia will have access to clinical evidence, on effectiveness of immunotherapeutic interventions, to deploy evidence-based treatment interventions with improved patient selection that improve outcomes in real life, i.e. in routine healthcare, for patients with refractory cancers who often present with co-morbidities;National healthcare providers, policymakers and authorities in European regions, EU Member States and Associated Countries wil...

Expected Outcome:Proposals under this topic should aim to deliver results that are directed and tailored towards and contribute to all of the following expected outcomes:Patients will benefit from better access to earlier, more person-centred palliative care models including digital remote tools and options for home-based care.Carers will benefit from real-time information tools and better communication.Clinicians will benefit from guidelines on optimal patient referral and care predictions. Scope:This topic will contribute to the achievement of the EU Cancer Mission’s objective to provide better quality of life for cancer patients, their families and carers. The focus is on the development of innovative models for earlier, more precise and better integrated palliative care.According to an EU conference on innovative palliative care for people with cancer on 8 October 2024[1], palliative...

Expected Outcome:Proposals under this topic should aim to deliver results that are directed and tailored towards and contribute to all of the following expected outcomes:Healthy people and in particular people at risk will benefit from microbiome tests and programmes that can discover and predict their transition to cancer before the onset of disease.People will have a better understanding of risks and will be enabled to address risks early by following treatments or adapting their lifestyles, including nutrition and other interventions.Physicians will be able to start cancer treatments earlier with a higher success rate.Policy makers and authorities will be enabled to develop and implement advanced and strategic programmes addressing cancer prevention. Scope:This topic will contribute to the achievement of the EU Cancer Mission’s objective to achieve better cancer prevention and early d...

Expected Outcome:This topic aims to develop a wide capacity building programme between EU Member States/Associated Countries and Ukrainian cancer centres, to support improvement or development of research & innovation-related capacities and integration with cancer care.To this end, proposals should aim at delivering results that are directed and tailored towards and contribute to all of the following expected outcomes:Researchers, clinicians and health care professionals will have access to improved research capacities, supporting better integration with care.Patients and citizens will have access to improved screening, diagnostics and treatments, while increasing their participation in clinical trials. Scope:Ukraine has a very high cancer burden with more than 155,000 new diagnoses every year[1]. The country has also one of the highest childhood cancer mortality rates globally[2]. Dispa...

Expected Outcome:Proposals under this topic should aim to deliver results that are directed and tailored towards and contribute to the following expected outcomes:Improved understanding of care needs of older patients with cancer and approaches to address them;Older cancer patients gain access to innovative age-specific approaches and tools better tailored to their care needs;National healthcare providers, policymakers and authorities in European regions, EU Member States and Associated Countries have the evidence to implement tailored care for older cancer patients that have the potential to be implemented in routine treatment and follow-up care in their healthcare systems; Scope:This topic contributes to the EU Cancer Mission’s objective to improve quality of life of cancer patients. The focus is on cancer patients aged 65 years and above.Currently, older cancer patients represent the...

Expected Outcome:Proposals under this topic should aim to deliver results that are directed and tailored towards and contribute to all of the following expected outcomes:Researchers of different disciplines use advanced multiscale Virtual Human Twins (VHTs) to expand the knowledge and understanding of cancer onset and progressionHealthcare professionals and researchers have access to advanced VHT-based solutions that model cancer onset and progression over time, contributing to improve personalised treatmentsResearchers, healthcare professionals, innovators and citizens have access to cancer VHTs through the UNCAN.eu and the advanced Virtual Human Twin platforms Scope:Virtual human twins (VHTs) are digital representations and in-silico models of an individual’s health and disease at different levels of the human anatomy (e.g. cells, tissues, organs or organ systems) for the prevention, p...

Expected Outcome:This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination “Tackling diseases and reducing disease burden”. To that end, proposals under this topic should aim to deliver results that are directed at, tailored towards and contributing to all the following expected outcomes:The EU is reinforced as an internationally recognised driver of research and innovation in Rare Diseases (RD) and thereby substantially contributing to the achievement of the Sustainable Development Goals related to rare diseases.Research funders align, adopt and implement their RD research policies allowing for the optimal generation and translation of knowledge into meaningful health products and interventions responding to the needs of people living with a rare disease across Europe and globally.The RD research community at large benef...

Expected Outcome:Proposals are expected to contribute to one or more of the following:Robust AI models and systems capable of resisting different classes of adversarial manipulation;Innovative defence mechanisms for AI models and systems against new attack families;Methodologies for detecting and mitigating attacks, such as data poisoning, backdoor exploitation and misclassification;AI systems leveraging privacy-enhancing technologies that maintain data confidentiality and regulatory compliance, enabling trusted in-house AI deployments (e.g., for governments and enterprises). Scope:The increasing reliance on AI in cybersecurity, critical infrastructure, and decision-making processes raises concerns about the security and robustness of AI systems. As AI systems become more prevalent, they are increasingly targeted by adversarial attacks that manipulate inputs, compromise training data, or...

Expected Outcome:Proposals are expected to contribute to one or more of the following:Enhanced security frameworks for both hardware and software supply chains, building on root-of-trust architectures and secure lifecycle management;Secure and trusted chip architectures for next-generation computing and networking systems;Integrated security-by-design approaches in software development, aimed to be aligned with relevant regulatory requirements;Security testing methodologies, including formal verification approaches and AI-driven security testing methodologies;Standardised methodologies for hardware security assessment, also contributing to cybersecurity certification. Scope:The increasing complexity and globalisation of software and hardware supply chains introduce new vulnerabilities that cyber adversaries can exploit. Ensuring the security of both software and hardware components acros...

Expected Outcome:Proposals are expected to contribute to one or more of the following:Quantum-resistant cryptographic primitives, also other than lattice-based approaches if relevant, that enhance the security and privacy of digital wallets, both for natural persons and wallets, as well as the design and implementation of post-quantum solutions for entity authentication and authenticated key establishment over insecure networks;Formal verification tools, improved High-Assurance Cryptographic Software (HACS) approaches and their integration in software workflows, to provide strong security guarantees in post-quantum migration, and enable streamlined evidence-based evaluation of secure systems that use cryptography. Scope:The development of new digital signatures and advanced cryptographic schemes, tailored specifically to the use cases and requirements in the context of wallets/eIDs, for...

Expected Outcome:the project results are expected to contribute to the following outcomes:support for the development of EU production of stable isotopes that are essential for the manufacturing of radionuclides used in novel nuclear medicine therapies;strengthening of the resilience and security of the EU medical radioisotope supply chain by securing access to source materials, reducing dependence on third countries and enhancing industrial-scale production (including the sourcing of stable isotopes);leveraging of the knowledge and expertise of nuclear scientists, physicists and engineers in order to develop and optimise the processes for the EU-based production of stable isotopes, while contributing to Europe’s Beating Cancer Plan and implementing the Strategic Agenda for Medical Ionising Radiation Applications (SAMIRA). Scope:radiological and nuclear technologies are integral to moder...

Expected Outcome:the project results are expected to contribute to all of the following outcomes:access to cutting-edge infrastructure for researchers and research teams from Euratom and Associated Countries to EU and international state-of-the-art nuclear research infrastructures;enhancing the network developed under the OFFERR project for optimised use of nuclear research infrastructures identified in the EU, thus supporting the implementation of the Euratom programme’s objectives and the establishment of the European Research Area (ERA) in the nuclear safety and radiation protection field;strengthened cross-border collaboration in nuclear safety and radiation protection research in the EU, a significant increase in transnational nuclear research and the fostering of shared expertise and resources;preservation of critical facilities, possibly increasing their number to ensure the long-...

Expected Outcome:the project results are expected to contribute to some of the following expected outcomes:research into safety of innovative reactors, small modular reactors (SMRs) – both light water SMRs (LW-SMRs) and Gen-IV-based advanced modular reactors (AMRs); design or demonstration of SMRs and fuel cycles’ viability; and efficient integration within low-carbon and smart energy systems;research support towards a shared and consistent approach among regulators’ TSOs to safety requirements for different advanced energy systems and applications (e.g. industrial heat, district heat and the maritime sector), supported by regular exchanges and reviews and workshops with licensees, SMR developers, and research organisations, thereby further improving safety across the EU;emphasis on innovation in the safety aspects of LW-SMRs and AMRs;establishment of operating rules for specific service...

Expected Outcome:the project’s results are expected to contribute to some of the following expected outcomes.Continuing safety assessment and long-term operation compliance that address technical challenges, regulatory expectations and economic competitiveness goals. Licence-holders and regulators will ensure the successful implementation of the requirements of the Nuclear Safety Directive [1], Basic Safety Standards Directive [2], Radioactive Waste Management Directive [3] and topical peer reviews [4] for current and planned nuclear power plants and research reactors.Safety assessment of ageing management programmes and optimisation of safety solutions; as well as the development and validation of advanced tools for ageing management and evaluation of reactors’ safety margins. The aim is to prevent and mitigate risks (including those associated with severe accidents) by using innovative...

Objective:The Pericles IV programme has the following general objective:To prevent and combat counterfeiting and related fraud, preserve the integrity of the euro banknotes and coins, thus strengthening the trust of citizens and business in the genuineness of these banknotes and coins and therefore enhancing the trust in the Union's economy, while securing the sustainability of public finances.The Pericles IV programme has the following specific objective:To protect euro banknotes and coins against counterfeiting and related fraud, by supporting and supplementing the measures undertaken by the Member States and assisting the competent national and Union authorities in their efforts to develop among themselves and with the Commission a close and regular cooperation and an exchange of best practice, where appropriate including third countries and international organisations.